finnCap disclosed Proteome Sciences PLC (LON:PRM), supporting its price target at 12.00GBX earlier today
- Updated: November 29, 2016
Having a price of 5.63GBX, Proteome Sciences PLC (LON:PRM) traded -3.83% lower on the day. With the last close down -57.68% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.03% over the same period. PRM has recorded a 50-day average of 7.59GBX and a two hundred day average of 13.35GBX. Trade Volume was down over the average, with 212,017 shares of PRM changing hands under the typical 631,196
Reporting a potential upside of 1.13%, finnCap hold steady the price target of Proteome Sciences PLC (LON:PRM) at 12.00GBX
On 2/29/2016, finnCap released a statement on Proteome Sciences PLC (LON:PRM) maintained the target price at 38.00GBX that suggested an upside of 0%.
Recent Performance Chart
Proteome Sciences PLC has with a one year low of 5.00GBX and a one year high of 23.94GBX and has a market capitalization of 0 GBX.
A total of 1 analyst has released a report on Proteome Sciences PLC. zero analysts rating the company a strong buy, zero analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 38.00GBX.
General Company Details For Proteome Sciences PLC (LON:PRM)
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.